Can CT Enteroclysis Predict the Outcome of Crohn's Disease

This study is ongoing, but not recruiting participants.

First Received: December 11, 2007 No Changes Posted

Sponsored by:	Indiana University
Information provided by:	Indiana University
ClinicalTrials.gov Identifier:	NCT00572780

Purpose

Specific CT Enteroclysis findings with or without other clinical and laboratory variables, can identify Crohn's disease patients who will response to medical therapy versus those who will either fail and require surgery or have uncontrolled disease.

Condition
Crohn's Disease

Genetics Home Reference related topics: Crohn disease

MedlinePlus related topics: Crohn's Disease

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Retrospective
Official Title:	Can CT Enteroclysis Predict the Response to Therapy and Outcome in Patient With Crohn's Disease

Further study details as provided by Indiana University:

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	2000
Study Start Date:	August 2007
Estimated Study Completion Date:	August 2009

Groups/Cohorts
CTE with CD Crohn's disease patients who underwent a CT enteroclysis as part of their clinical evaluation for symptomatic Crohn's disease.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Crohn's disease patients that have had a CT Enteroclysis as part of their clinical evaluation for symptomatic Crohn's disease will be eligible.

Subjects who were later diagnosied with bowel malignancy and subjects with a period of follow-up of less than 1 year(without surgery) will be excluded.

Criteria

Inclusion Criteria:

Crohn's disease with CT Enteroclysis during symptomatic treatment

Exclusion Criteria:

Crohn's disease subjects who have had a follow-up less than 1 year, without surgery
Crohn's disease subjects that were later diagnosed with a bowel malignancy

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00572780

Locations

United States, Indiana
Indiana University
Indianapolis, Indiana, United States, 46202

Sponsors and Collaborators

Indiana University

Investigators

Principal Investigator:

Michael V. Chiorean, M.D.

Indiana University

More Information

No publications provided

Responsible Party:	Indiana University ( Michael V. Chiorean M.D. )
Study ID Numbers:	070759
Study First Received:	December 11, 2007
Last Updated:	December 11, 2007
ClinicalTrials.gov Identifier:	NCT00572780 History of Changes
Health Authority:	United States: Institutional Review Board

Keywords provided by Indiana University:

Crohn's Disease
CT Enteroclysis

Study placed in the following topic categories:

Crohn's Disease
Digestive System Diseases
Gastrointestinal Diseases
Ileitis
Enteritis

Crohn Disease
Inflammatory Bowel Diseases
Gastroenteritis
Intestinal Diseases
Ileal Diseases

Additional relevant MeSH terms:

Digestive System Diseases
Gastrointestinal Diseases
Ileitis
Enteritis
Crohn Disease

Inflammatory Bowel Diseases
Intestinal Diseases
Gastroenteritis
Ileal Diseases

ClinicalTrials.gov processed this record on May 07, 2009